The PCR (polymerase chain reaction) sequencer can amplify bacterial DNA up to 1,000 times. Any routine diagnosis requires a minimum of 10 to 80 bacteria, which means that PCR is highly sensitive.This factor has been used in countless diagnostic procedures.PCR (polymerase chain reaction) sequencing machines do not yet need to purify bacterial samples because they have specific sequences that identify bacterial DNA.The versatility of PCR has proven to be a great advantage, and the diagnosis of many dangerous diseases (such as tuberculosis, pneumonia, etc.) is aimed at determining whether the strain is resistant.This greatly improves the success rate of treatment.
This report contains market size and forecasts of Polymerase Chain Reaction (PCR) Sequencer in global, including the following market information:
Global Polymerase Chain Reaction (PCR) Sequencer Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Polymerase Chain Reaction (PCR) Sequencer Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Polymerase Chain Reaction (PCR) Sequencer companies in 2021 (%)
The global Polymerase Chain Reaction (PCR) Sequencer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Real Time PCR Sequencer Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Polymerase Chain Reaction (PCR) Sequencer include Thermo Fisher Scientific, Generi Biotech, ZyGEM, Bio-Rad Laboratories, GE Healthcare, BD, Abbott, Beckman Coulter (Danaher Corporation) and Affymetrix, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Polymerase Chain Reaction (PCR) Sequencer manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Polymerase Chain Reaction (PCR) Sequencer Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Polymerase Chain Reaction (PCR) Sequencer Market Segment Percentages, by Type, 2021 (%)
Real Time PCR Sequencer
Standard PCR Sequencer
Digital PCR Sequencer
Others
Global Polymerase Chain Reaction (PCR) Sequencer Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Polymerase Chain Reaction (PCR) Sequencer Market Segment Percentages, by Application, 2021 (%)
Research
Diagnostic
Biopharma
Others
Global Polymerase Chain Reaction (PCR) Sequencer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Polymerase Chain Reaction (PCR) Sequencer Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Polymerase Chain Reaction (PCR) Sequencer revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Polymerase Chain Reaction (PCR) Sequencer revenues share in global market, 2021 (%)
Key companies Polymerase Chain Reaction (PCR) Sequencer sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Polymerase Chain Reaction (PCR) Sequencer sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Generi Biotech
ZyGEM
Bio-Rad Laboratories
GE Healthcare
BD
Abbott
Beckman Coulter (Danaher Corporation)
Affymetrix
Sigma Aldrich Corporation
Roche
QIAGEN
Agilent
Analytik Jena
Bioer
Esco
ELITech Group